DoD Military Burn, Idea Development Award | W81XWH 21 MBRP IDA

Opportunity Information: Apply for W81XWH 21 MBRP IDA

The DoD Military Burn, Idea Development Award (FY21 MBRP IDA; Funding Opportunity Number W81XWH-21-MBRP-IDA) is a Department of Defense funding opportunity run through the Congressionally Directed Medical Research Programs (CDMRP) to spark innovative, military-relevant burn research. The core purpose is to move the field forward by supporting new ideas that either introduce a genuinely different way of thinking, challenge established assumptions, or reframe persistent burn-related problems from a fresh angle. The program is aimed at work that can realistically contribute to improved burn care and outcomes for Service Members, Veterans, other military beneficiaries, and by extension the broader public.

In terms of what kinds of science are eligible, the award is positioned for applied research and preclinical research. It is not meant to fund fundamental basic research that is too early or disconnected from practical burn needs, and it also does not support clinical research or clinical trials. This distinction matters because the program is looking for projects that can generate actionable preclinical evidence and push toward solutions that could ultimately affect care, without directly enrolling or prospectively assigning human subjects to interventions under this mechanism. If a proposal crosses into CDMRP-defined clinical research or a clinical trial, it will be considered non-responsive for this award and should instead be directed to a different MBRP mechanism focused on clinical translation.

Impact is treated as a make-or-break element. Applicants are expected to clearly spell out why the work matters and how it could change burn research and/or burn patient care if successful, both in the near term and longer term, specifically in relation to the FY21 MBRP Focus Area. The program highlights a particular interest in burn care interventions and concepts that can scale to mass casualty situations, reflecting operational realities where large numbers of burn injuries could occur and systems need solutions that remain effective under surge conditions. Competitive proposals are expected to present a strong scientific rationale, logical reasoning, and a well-formed, testable hypothesis rather than open-ended exploration.

Unlike many early-stage ideation awards, this one requires evidence that the idea is already grounded in data. Preliminary data and/or published results relevant to the project are required, and if unpublished preliminary findings are included, they must come from the Principal Investigator’s lab or from members of the project team. In other words, the application cannot rely solely on external unpublished observations or speculative feasibility claims; it needs credible, internally sourced support that the approach can be tested and is technically plausible.

The award also places heavy emphasis on military relevance and encourages collaboration, especially partnerships that connect military or Veteran institutions with non-military research organizations. The logic is that these collaborations can combine strengths such as unique patient populations, specialized infrastructure, operational knowledge, biorepositories, or data resources, increasing the chance that preclinical work is aligned with real-world military burn needs and can be translated later. If a project depends on access to DoD or VA resources or databases, the application must describe that access up front and include a plan to maintain it throughout the project.

From a funding and administrative standpoint, the DoD will make the awards as assistance agreements, meaning funding is provided to support a public purpose rather than to procure goods or services for direct government use. Assistance agreements may be issued as either a grant or a cooperative agreement, and which one you receive depends on how much substantial involvement the DoD anticipates during performance. If the agency expects minimal involvement, it is more likely to be a grant; if collaboration, participation, or other direct engagement from the agency is expected, it may be a cooperative agreement. The total budget for an individual FY21 MBRP IDA project is capped at $600,000 in total costs over the entire period of performance, and CDMRP indicated an overall plan to commit roughly $2.4 million total to fund about four awards, assuming federal funds are available and proposals score well in scientific and programmatic review. Awards were expected to be made no later than September 30, 2022, and the FY21 funds anticipated for these awards were described as expiring for use on September 30, 2027, which effectively sets the outer boundary on when those appropriated dollars can be spent.

The announcement also lays out compliance expectations for studies involving human-derived materials and animal work, even though clinical studies are not allowed. If the research uses human anatomical substances, it must go through the USAMRDC Office of Research Protections Human Research Protection Office (HRPO) administrative review and approval before the work can begin, in addition to any local IRB or ethics review that may apply. Local IRB approval is not required at submission, but investigators are told to plan for at least about three months for HRPO processing. For animal research, projects must be reviewed by the USAMRDC Animal Care and Use Review Office (ACURO) in addition to the local IACUC, with applicants advised to plan for roughly three to four months for ACURO review. On the research quality side, applicants are expected to design preclinical studies with rigor and reproducibility in mind, including principles such as randomization, blinding, sample size estimation, and transparent data handling, and to use recognized reporting frameworks like the ARRIVE guidelines.

Finally, the program signals an expectation that data and resources generated with these federal funds should be shared with the broader research community and the public when appropriate, consistent with CDMRP guidance. Eligibility is described as unrestricted (open to various entity types, subject to any additional eligibility language in the full announcement). Key administrative details include the posting date of April 29, 2021, an original closing date of September 30, 2021, an activity area of science and technology/R&D, and administration by the Department of Defense (Department of the Army, USAMRAA) under CFDA 12.420.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Military Burn, Idea Development Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Apr 29, 2021.
• Applicants must submit their applications by Sep 30, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 4 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 21 MBRP IDA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: